NeuroOne Medical Technologies (NASDAQ:NMTC) Posts Quarterly Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTC) issued its quarterly earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative net margin of 308.51% and a negative return on equity of 276.12%.

NeuroOne Medical Technologies Trading Up 13.7 %

Shares of NMTC opened at $0.86 on Tuesday. The firm’s fifty day simple moving average is $0.82 and its 200-day simple moving average is $0.84. The firm has a market capitalization of $26.50 million, a price-to-earnings ratio of -1.58 and a beta of 0.54. NeuroOne Medical Technologies has a twelve month low of $0.55 and a twelve month high of $1.72.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.